152 related articles for article (PubMed ID: 27438325)
1. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection.
Zanni MV; Toribio M; Robbins GK; Burdo TH; Lu MT; Ishai AE; Feldpausch MN; Martin A; Melbourne K; Triant VA; Suchindran S; Lee H; Hoffmann U; Williams KC; Tawakol A; Grinspoon SK
JAMA Cardiol; 2016 Jul; 1(4):474-80. PubMed ID: 27438325
[TBL] [Abstract][Full Text] [Related]
2. Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection.
Tawakol A; Ishai A; Li D; Takx RA; Hur S; Kaiser Y; Pampaloni M; Rupert A; Hsu D; Sereti I; Fromentin R; Chomont N; Ganz P; Deeks SG; Hsue PY
JAMA Cardiol; 2017 Feb; 2(2):163-171. PubMed ID: 27926762
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid Receptor Antagonism by Eplerenone and Arterial Inflammation in HIV: The MIRABELLA HIV Study.
Srinivasa S; Abohashem S; Walpert AR; Dunderdale CN; Iyengar S; Shen G; Jerosch-Herold M; deFilippi CR; Robbins GK; Lee H; Kwong RY; Adler GK; Tawakol A; Grinspoon SK
JAMA Cardiol; 2024 Feb; 9(2):189-194. PubMed ID: 38090987
[TBL] [Abstract][Full Text] [Related]
4. Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT.
Lawal IO; Ankrah AO; Popoola GO; Lengana T; Sathekge MM
J Nucl Cardiol; 2019 Aug; 26(4):1258-1265. PubMed ID: 29417417
[TBL] [Abstract][Full Text] [Related]
5. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.
Okulicz JF; Le TD; Agan BK; Camargo JF; Landrum ML; Wright E; Dolan MJ; Ganesan A; Ferguson TM; Smith DM; Richman DD; Little SJ; Clark RA; He W; Ahuja SK
JAMA Intern Med; 2015 Jan; 175(1):88-99. PubMed ID: 25419650
[TBL] [Abstract][Full Text] [Related]
6. Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
Prendergast AJ; Szubert AJ; Berejena C; Pimundu G; Pala P; Shonhai A; Musiime V; Bwakura-Dangarembizi M; Poulsom H; Hunter P; Musoke P; Kihembo M; Munderi P; Gibb DM; Spyer M; Walker AS; Klein N;
J Infect Dis; 2016 Jul; 214(2):226-36. PubMed ID: 27190179
[TBL] [Abstract][Full Text] [Related]
7. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
[TBL] [Abstract][Full Text] [Related]
8. Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.
Crowell TA; Fletcher JL; Sereti I; Pinyakorn S; Dewar R; Krebs SJ; Chomchey N; Rerknimitr R; Schuetz A; Michael NL; Phanuphak N; Chomont N; Ananworanich J;
J Int AIDS Soc; 2016; 19(1):21163. PubMed ID: 27637172
[TBL] [Abstract][Full Text] [Related]
9. Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.
Hammoud DA; Boulougoura A; Papadakis GZ; Wang J; Dodd LE; Rupert A; Higgins J; Roby G; Metzger D; Laidlaw E; Mican JM; Pau A; Lage S; Wong CS; Lisco A; Manion M; Sheikh V; Millo C; Sereti I
Clin Infect Dis; 2019 Jan; 68(2):229-238. PubMed ID: 30215671
[TBL] [Abstract][Full Text] [Related]
10. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Front Immunol; 2019; 10():1965. PubMed ID: 31507593
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).
Nixon DE; Bosch RJ; Chan ES; Funderburg NT; Hodder S; Lake JE; Lederman MM; Klingman KL; Aberg JA;
J Clin Lipidol; 2017; 11(1):61-69. PubMed ID: 28391912
[TBL] [Abstract][Full Text] [Related]
12. Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment.
Dijkstra M; Prins H; Prins JM; Reiss P; Boucher C; Verbon A; Rokx C; de Bree G
BMJ Open; 2021 Nov; 11(11):e048582. PubMed ID: 34845066
[TBL] [Abstract][Full Text] [Related]
13. Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
Bernal S; Puertas MC; Morón-López S; Cranston RD; Urrea V; Dalmau J; Salgado M; Gálvez C; Erkizia I; McGowan I; Scherrer D; Revollo B; Sirera G; Santos JR; Clotet B; Paredes R; Martinez-Picado J
J Infect Dis; 2023 Nov; 228(9):1280-1291. PubMed ID: 37395474
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
Marconi VC; Moser C; Gavegnano C; Deeks SG; Lederman MM; Overton ET; Tsibris A; Hunt PW; Kantor A; Sekaly RP; Tressler R; Flexner C; Hurwitz SJ; Moisi D; Clagett B; Hardin WR; Del Rio C; Schinazi RF; Lennox JJ
Clin Infect Dis; 2022 Jan; 74(1):95-104. PubMed ID: 33693561
[TBL] [Abstract][Full Text] [Related]
15. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?
Stein JH; Currier JS; Hsue PY
JACC Cardiovasc Imaging; 2014 May; 7(5):515-25. PubMed ID: 24831212
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.
Erlandson KM; Ng DK; Jacobson LP; Margolick JB; Dobs AS; Palella FJ; Lake JE; Bui H; Kingsley L; Brown TT
J Infect Dis; 2017 Jan; 215(2):228-237. PubMed ID: 27799351
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
Li N; Zheng HY; He WQ; He XY; Li R; Cui WB; Yang WL; Dong XQ; Shen ZQ; Zheng YT
AIDS; 2024 May; 38(6):803-812. PubMed ID: 38578958
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Enzyme Alterations in HIV Patients on Antiretroviral Therapy: A Case-Control Study in a Hospital Setting in Ghana.
Osakunor DN; Obirikorang C; Fianu V; Asare I; Dakorah M
PLoS One; 2015; 10(8):e0134449. PubMed ID: 26247879
[TBL] [Abstract][Full Text] [Related]
19. HIV related hypochlorhydria does not appear to respond to anti-retroviral therapy in Zambian adults: a case control study.
Kayamba V; Shibemba A; Zyambo K; Heimburger DC; Morgan D; Kelly P
Pan Afr Med J; 2018; 31():128. PubMed ID: 31037188
[TBL] [Abstract][Full Text] [Related]
20. Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort.
Nakanjako D; Nabatanzi R; Ssinabulya I; Bayigga L; Kiragga A; Banturaki G; Castelnuovo B
Heliyon; 2024 Jun; 10(11):e31910. PubMed ID: 38882354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
